CPT® Code 86316

A quantitative immunoassay for tumor antigen, coded as CPT® 86316, is a laboratory test that measures the levels of specific tumor antigens in the serum. Tumor antigens, also known as tumor markers, are substances produced by cancer cells or by the body in response to cancer. The presence of significant levels of these antigens can indicate the presence of malignancy. This particular code encompasses a range of tumor antigens that are not specified elsewhere in the coding system. Examples of tumor antigens associated with this code include CA 50, CA 72-4, and CA 549. Each of these antigens is linked to specific types of cancers; for instance, CA 50 is primarily associated with gastrointestinal cancers such as pancreatic, gastric, colorectal, and hepatic carcinomas. CA 72-4 is utilized in the detection of gastrointestinal and breast cancers, while CA 549 is specifically relevant for breast cancer patients. Various immunoassay techniques are employed to detect these tumor antigens, including the use of monoclonal antibodies and radioimmunoassay for CA 50, CA 72-4, and CA 549. Additionally, soluble mesothelin-related peptides, another tumor antigen tested under this code, are evaluated using enzyme-linked immunosorbent assay (ELISA) to assist in the management of mesothelioma. Other methods such as enzyme immunoassay and chemiluminescent immunoassay may also be utilized for different tumor antigens. Regular testing of tumor antigens is an important part of cancer management, as it helps in monitoring the progression or regression of the disease in conjunction with other clinical assessments.